These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Comparative studies on recurrence and relapse rate in peptic ulcer treated with various types of anti-ulcer agent; inhibitors of initiating factors causing peptic ulcer]. Ishikawa M; Saito H; Sato J Nihon Rinsho; 1988 Jan; 46(1):69-78. PubMed ID: 2897486 [No Abstract] [Full Text] [Related]
24. [Medical and surgical trends in the treatment of peptic ulcer: importance of clinico-endoscopic preselection and follow-up]. Mirelli E; De Marzo V; Siardi C; Bozzolo P Clin Ter; 1982 Jul; 102(1):3-13. PubMed ID: 6128097 [No Abstract] [Full Text] [Related]
25. Omeprazole in infants with cimetidine-resistant peptic esophagitis. Alliët P; Raes M; Bruneel E; Gillis P J Pediatr; 1998 Feb; 132(2):352-4. PubMed ID: 9506656 [TBL] [Abstract][Full Text] [Related]
26. [New class of pharmacological preparations: histamine H2-receptors blockaders (a review of the literature)]. Ionov ID Farmakol Toksikol; 1978; 41(5):624-32. PubMed ID: 81139 [No Abstract] [Full Text] [Related]
27. Pharmacology update. Anti-peptic ulcer agents--Part I. A histamine 2 receptor antagonist. Romankiewicz JA J Pract Nurs; 1981 Jan; 31(1):15-6. PubMed ID: 6108367 [No Abstract] [Full Text] [Related]
28. [Antagonists of the histamine H2 receptors in the stomach]. Landa L Gac Med Mex; 1981 Dec; 117(12):472-4. PubMed ID: 6123460 [No Abstract] [Full Text] [Related]
29. Directives, methods and suggestions for anti-ulcer drug therapy. Varró V Ther Hung; 1985; 33(3):125-31. PubMed ID: 2876535 [No Abstract] [Full Text] [Related]
30. [Cimetidine and recent H2-receptor blocking agents in the therapy of gastrointestinal diseases]. Gugler R; Musch E Med Welt; 1982 Aug; 33(31-32):1083-86. PubMed ID: 6127590 [No Abstract] [Full Text] [Related]
31. [Drug treatment of reflux esophagitis: effects of strong gastric acid inhibition]. Jansen JB; Lamers CB Ned Tijdschr Geneeskd; 1989 Apr; 133(13):662-5. PubMed ID: 2566126 [No Abstract] [Full Text] [Related]
32. [H2-blockers in reflux-esophagitis]. Berstad A Tidsskr Nor Laegeforen; 1983 Jul; 103(19-21):1439-41. PubMed ID: 6138879 [No Abstract] [Full Text] [Related]
33. How do you spell relief in reflux esophagitis? PPI! Fennerty MB Gastroenterology; 1996 Sep; 111(3):826-7. PubMed ID: 8780593 [No Abstract] [Full Text] [Related]
34. [Indications and successes of conservative therapy in gastroenterology: peptic ulcer]. Gugler R Z Gastroenterol Verh; 1989 Jul; 24():82-4. PubMed ID: 2474995 [No Abstract] [Full Text] [Related]
35. [Drug therapy and therapeutic tactics in gastroduodenal ulcer]. Grigor'ev PIa; Isakov VA; Iakovenko EP Ter Arkh; 1988; 60(8):118-26. PubMed ID: 2906485 [No Abstract] [Full Text] [Related]
36. Your CE topic this month (No. 9). Peptic ulcer disease. Perentesis GP; Kirschenbaum HL; Piltz GW J Pract Nurs; 1983; 33(8):35-43. PubMed ID: 6140312 [No Abstract] [Full Text] [Related]
37. Update on peptic ulcer drugs. Aronson B Am J Nurs; 1998 Jan; 98(1):41-6. PubMed ID: 9455332 [No Abstract] [Full Text] [Related]
38. [Current aspects of the therapy of gastroduodenal peptic ulcer]. Castro Lde P Rev Hosp Clin Fac Med Sao Paulo; 1983; 38(2):90-102. PubMed ID: 6139870 [No Abstract] [Full Text] [Related]